Introduction Existing methods to detect breast cancer in asymptomatic patients have limitations, and there is a need to develop more accurate and convenient methods. In this study, we investigated whether early detection of breast cancer is possible by analyzing gene-expression patterns in peripheral blood cells.
Nuclear receptors are ligand-modulated transcription factors that transduce the presence of lipophilic ligands into changes in gene expression. Nuclear receptor activity is regulated by ligand-induced interactions with coactivator or corepressor molecules. From a positive hormone response element (pHRE) and in the absence of hormone, corepressors SMRT and N-CoR are bound to some nuclear receptors such as the thyroid hormone (T3Rs) and retinoic acid receptors and mediate inhibition of basal levels of transcription. Ligand binding results in dissociation of corepressors and association of coactivators, resulting in the reversal of inhibition and a net activation of transcription. However, the role of cofactors on the activity of nuclear receptors from negative HREs (nHREs) is poorly understood. Here we show that corepressor SMRT can act as a potent coactivator for T3R␣ from a nHRE; N-CoR has a similar but significantly attenuated activity. Mutagenesis of residues in the hinge region of T3R␣ that block binding of SMRT and N-CoR inhibits ligand-independent transcriptional activation by T3R␣ from a nHRE. These mutations also abrogate SMRT-mediated increase in transcriptional activity by T3R␣ at a nHRE without significantly affecting ligand-dependent activation at a pHRE. Partial protease digestion coupled to the mobility shift assay indicate differences in the conformation of T3R␣-SMRT complexes bound to a pHRE versus a nHRE. These results suggest that allosteric changes resulting from binding of T3R␣ to different response elements, i.e. pHREs versus nHREs, dictate whether a cofactor will function as a coactivator or a corepressor. This, in turn, greatly expands the repertoire of mechanisms used in modulating transcription without the need for expression of new regulatory molecules.Transcriptional regulation is fundamental to the normal functioning of the cell and is achieved through positively or negatively acting transcription factors (1, 2). Whereas in some cases the transcription factors that activate and repress gene expression are encoded by different genes, increasingly more transcription factors are now recognized to function both as an activator and a repressor depending on the nature of the response element that they interact with and the cellular context (1, 2). However, the details of how an activating transcription factor can become a repressor and vice versa is not well understood.One of the factors that can serve as a transcriptional activator or repressor depending on the response element and cellular context is the thyroid hormone receptor (T3R) 1 (3, 4), which belongs to the nuclear receptor superfamily of ligand modulated transcriptional factors (for reviews, see Refs. 5 and 6). Recent studies have begun to uncover the molecular details of this bimodal activity on a positive hormone response element (pHRE). In the absence of hormone, T3R associates with corepressor molecules, such as SMRT and N-CoR (7-9), which assemble a repressive complex that shuts down transcription (reviewed in Refs. 5 and 6)....
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.